Immune Pharmaceuticals – Securities Investigation
Are you concerned about your investment in Immune Pharmaceuticals? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
Immune Pharmaceuticals Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases.
The company filed a Form D (private placement) notice of exempt offering of securities in 2014 to raise capital from investors. The total offering amount was $11,720,475.
Investors may have claims.
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly selling alternative investment products like Immune Pharmaceuticals to investors.
Private placements are a means for smaller companies to raise capital through the sale of equity or debt securities without having to register their securities with the SEC. These investments are often riskier and more complicated than traditional investments, and are only suitable for high net worth, sophisticated investors.
Broker dealers are required to perform adequate due diligence on any investment they recommend. They must ensure that all recommendations are suitable for the investor. Recommendations should be in line with the investor’s age, risk tolerance, net worth, and investment experience.
Despite the risks of investing in this type of alternative investments, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation.
If you are concerned about your investment in Immune Pharmaceuticals or another private placement investment and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510 for a free consultation.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://www.whitesecuritieslaw.com.
Tags: Immune Pharmaceuticals class action, Immune Pharmaceuticals complaints, Immune Pharmaceuticals distributions, Immune Pharmaceuticals investigation, Immune Pharmaceuticals lawsuit, Immune Pharmaceuticals losses, Immune Pharmaceuticals value, investment fraud attorney, Securities Attorney, Securities Lawyer Last modified: February 19, 2019